Related Experiment Video
Updated: Jun 18, 2025

Measuring Glucose Uptake in Drosophila Models of TDP-43 Proteinopathy
Published on: August 3, 2021
A Rare Presentation of Glucose-6-Phosphate Dehydrogenase Deficiency
Neha Tyagi1, Varsha Premkumar1, Manojkumar G Patil1
1Pediatrics, Dr. D. Y. Patil Medical College, Hospital and Research Centre, Pune, IND.
Insights
Glucose-6-phosphate dehydrogenase (G6PD) deficiency affects 400 million globally. A viral infection and NSAID use triggered acute liver failure and hemolysis in a child with G6PD deficiency.
Area of Science:
- Genetics and Enzymology
- Pediatric Gastroenterology and Hematology
Background:
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a prevalent X-linked hereditary genetic disorder affecting approximately 400 million individuals worldwide.
- This condition arises from mutations in the G6PD gene, leading to functional enzyme variants and diverse clinical manifestations.
Observation:
- A 12-year-old male presented with acute liver failure.
- The patient subsequently developed signs of hemolysis.
- Differential diagnoses included acetaminophen toxicity and hepatitis A.
Findings:
- The clinical presentation was ultimately attributed to an underlying G6PD deficiency.
- The deficiency was exacerbated by a concurrent viral infection.
- Simultaneous ingestion of non-steroidal anti-inflammatory drugs (NSAIDs) also contributed to the adverse events.
Implications:
- Highlights the critical need to consider G6PD deficiency in pediatric patients presenting with acute liver failure and hemolysis, especially when exposed to certain triggers.
- Emphasizes the potential for drug-induced hemolytic anemia and liver injury in individuals with G6PD deficiency.
- Underscores the importance of accurate diagnosis and avoidance of inciting agents like NSAIDs and certain infections in managing G6PD deficiency.
Abstract:
Approximately 400 million individuals globally experience glucose-6-phosphate dehydrogenase (G6PD) insufficiency, an enzymatic condition that may be hazardous. Because of mutations in the G6PD gene, which result in functional variants alongside a variety of biochemical and clinical symptoms, this condition is an X-linked hereditary genetic disorder. Our case is that of a 12-year-old male child who presented with acute liver failure and later on, exhibited signs of hemolysis as well. We had to rule out the possibilities of acetaminophen toxicity and hepatitis A before reaching the conclusion that an underlying G6PD deficiency was being exacerbated by viral infection and simultaneous ingestion of non-steroidal anti-inflammatory drugs (NSAIDs).
More Related Videos
13:35Structural Biology and Analytical Chemistry Approaches for Characterizing C-Glycoside Metabolic Enzymes in Human Gut Microbiota
Published on: May 23, 2025
07:04Measuring Uptake of the Glucose Analog, 6-(N-(7-Nitrobenz-2-Oxa-1,3-Diazol-4-yl)Amino)-6-Deoxyglucose, in Intact Murine Neural Retina
Published on: March 14, 2025
Related Concept Videos
Inborn Errors of Metabolism
Glucose Transporters
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hypoglycemia and Glucagon
Energy-requiring Steps of Glycolysis
Glycolysis: Preparatory Phase
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...